Abstract:Ling Zhou, 1 Juanjuan Wang, 1 Hui Hou, 1 Jiao Li, 1 Juan Li, 1 Jiannan Liang, 1 Junqin Li, 1 Xuping Niu, 1 Ruixia Hou, 1 Kaiming Zhang 2 1 Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital, Taiyuan, People's Republic of China Correspondence: Kaiming Zhang, Taiyuan Central Hospital, Taiyuan, People's Republic of China, Tel/Fax +86-351-5656080, Email ; Objective: Autophagy, an intracellular process of self-digestion, has been shown to modulate inflammatory responses. In the present study, we determined the effects of autophagy on inflammatory response induced by M5 cytokines. Methods: Human umbilical vein endothelial cells (HUVECs) were treated with M5 cytokines to induce inflammation. Expression levels of mRNA for inflammatory cytokines and BIRC2 were compared in HUVECs with vs without induction of autophagy with rapamycin (RAPA) by PCR, while cell apoptosis was assessed by flow cytometry and caspase-3 activity assay kit. Expression levels of LC3, p62, p-p38 MAPK (Thr180/Tyr182), p-mTOR (Ser2445) and p-ULK1 (Ser555) proteins were measured by Western blotting. The nitric oxide (NO) content, NO synthase (NOS) activity and cell angiogenesis were also evaluated. Results: Induction of autophagy with RAPA decreased expression levels of IL6, IL8 and CCL20, in addition to reduction in inflammation-induced apoptosis in HUVECs. Moreover, RAPA increased LC3II, while decreasing p62 expression. Likewise, expression levels of p-p38 MAPK and p-mTOR proteins were markedly decreased by the treatment with RAPA. Finally, RAPA treatment increased the NO content and the NOS activity, and inhibited angiogenesis. Conclusion: Induced autophagy can improve the function of endothelial cells in psoriasis, suggesting approaches to induce autophagy can be used to ameliorate psoriasis. Keywords: autophagy, inflammatory, HUVECs, p38 MAPK/mTOR Autophagy is an evolutionarily conserved catabolic process that degrades cytoplasmic materials and provides a substrate for energy metabolism during nutrient deficiency and metabolic stress in order to maintain cellular homeostasis and adapt to adverse environments. 1–5 Alterations of autophagy are associated with a number of inflammatory diseases, including psoriasis. 6,7 A large number of studies have shown that autophagy and autophagy-related proteins are involved in immune regulation, such as intracellular bacterial clearance, secretion of inflammatory cytokines, antigen presentation and lymphocyte development. 6,8 Autophagy is initiated by inducing autophagy genes for microtubule-associated protein light chain 3 (LC3), Beclin-1 and other autophagy-related proteins, which all play an important role in the maintenance cell homeostasis under physiological and pathological conditions. 9–11 The regulation of autophagy is a very complex process. Mammalian target of rapamycin (mTOR), phosphoinositide 3-kinase (PI3K)/Akt, MAPK and other pathways are considered as major regulatory pathways of autophagy and have been widely studied. 12,13 Mammalian rapamycin mechanistic target is a typical inhibitor of autophagy, which is related to growth factor nutrient and energy signals. Rapamycin can inhibit mTOR complex 1 (mTORC1), which effectively inhibits autophagy by phosphorylating ULK1. In addition to regulation of autophagy, the mTORC1 signaling pathway also regulates various processes in innate immune cells through various mechanisms such as metabolic protein translation and antigen presentation. 14 In addition, mitogen-activated protein kinase (MAPK) signaling pathway regulated cell growth and differentiation. MAPK pathway is also considered to be the main regulation pathway of autophagy. 15 Psoriasis is a chronic, multifactorial, immune-mediated skin disease. 16 Psoriasis is considered as a systemic disease because psoriatic inflammation is involved both cutaneous and extracutaneous tissues. 17 Previous studies demonstrated that abnormal autophagy contributes dermal angiogenesis, 18 neovascularization, and extravasation of inflammatory cells into the lumen in psoriasis. 19 Since autophagy deficiency can induce the production of proinflammatory cytokines by increasing the expression of p62, 20 inflammation in psoriatic endothelial cells could also be linked to altered autophagy. Therefore, we studied here the regulatory role of autophagy -Abstract Truncated-

MAPK P38/ulk1 Pathway Inhibits Autophagy and Induces IL-1β Expression in Hepatic Stellate Cells.

P38 MAPK Inhibits Autophagy and Promotes Hepatic Stellate Cells Inflammatory Responses via Atg13 During Acute-On-Chronic Liver Failure

Lipopolysaccharide Inhibits Autophagy and Promotes Inflammatory Responses Via P38 MAPK-Induced Proteasomal Degradation of Atg13 in Hepatic Stellate Cells

Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.

p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1

Autophagy and Apoptosis in MAC-T Cells Are Regulated through AMPK/mTOR/ULK1 Pathway Signaling

HMGB1-induced Autophagy Facilitates Hepatic Stellate Cells Activation: a New Pathway in Liver Fibrosis

Potentiation of Hepatic Stellate Cell Activation by Extracellular ATP is Dependent on P2X7R-mediated NLRP3 Inflammasome Activation

The Transcription Factor P8 Regulates Autophagy in Response to Palmitic Acid Stress Via a Mammalian Target of Rapamycin (Mtor)-Independent Signaling Pathway

Decreased Hepatocyte Autophagy Leads to Synergistic IL‐1β and TNF Mouse Liver Injury and Inflammation

Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells

Interleukin-1β upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells

Lipopolysaccharides Induce Smad2 Phosphorylation Through PI3K/Akt and MAPK Cascades in HSC-T6 Hepatic Stellate Cells

HSF-1 is Involved in Attenuating the Release of Inflammatory Cytokines Induced by LPS Through Regulating Autophagy

Lipopolysaccharide-Induced Dephosphorylation of AMPK-Activated Protein Kinase Potentiates Inflammatory Injury Via Repression of ULK1-Dependent Autophagy

ATRA-mediated-crosstalk between stellate cells and Kupffer cells inhibits autophagy and promotes NLRP3 activation in acute liver injury

Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo

Effect of mitogen-activated protein kinase pathway on Kupffer cell activation by lipopolysaccharide

MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways

P2X7 Receptor Inhibitor Suppressed Extracellular ATP/LPS-primed Human Hepatic Stellate Cells Activation Via Downregulating NLRP3 Inflammasome

Autophagy in inflammation: the p38α MAPK-ULK1 axis.